A Hong Kong man who died days after receiving the China-made Sinovac Covid-19 vaccine in 2022 died of natural causes, a jury has ruled in a coroner’s court inquest. A five-member jury on Thursday ...

It is time to act. Your vote at the upcoming Special Meeting of Shareholders will shape SINOVAC’s future. SAIF has called this Special Meeting to reconstitute a remnant of the Former Board that the UK ...

“[T]he [current] board appears to be working to pay SVA shareholders their fair share of dividends, and to resume trading of the company's shares, which are the two most pressing issues currently ...

BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the recent ...

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is ...

Court denies Vivo Capital's petition for relief relating to shareholder votes and corporate governance, clearing another legal hurdle for distribution of the US$55.00 per common share special cash ...